chemical restraints

Johnson & Johnson shares are rebounding as the drug maker recovers from federal charges it paid kickbacks to a pharmacy company to boost sales of its drugs to nursing-home patients. Meantime, the Food and Drug Administration accused it of being too slow with its product recall during a Tylenol scare.